Companion Diagnostic Technologies Market Report

USA Companion Diagnostic Technologies Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Oct 19, 2022
  • PAGES：154
  • REPORT CODE：GMM1300311
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Companion Diagnostic Technologies market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Companion Diagnostic Technologies market. Detailed analysis of key players, along with key growth strategies adopted by Companion Diagnostic Technologies industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Dako (Agilent Technologies)

    • Qiagen

    • Abbott Laboratories

    • Thermo Fisher Scientific

    • Resonance Health Ltd

    • Roche

    • Myriad Genetics

    • Danaher

    • Leica Microsystems

    • bioMerieux

    By Type:

    • Immunohistochemistry

    • Molecular Diagnostics

    By End-User:

    • Oncology

    • Cardiovascular

    • Central Nervous System

    • Auto immune & Inflammation

    • Virology

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Companion Diagnostic Technologies Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Companion Diagnostic Technologies Market Size and Growth Rate of Immunohistochemistry from 2016 to 2027

      • 1.3.2 USA Companion Diagnostic Technologies Market Size and Growth Rate of Molecular Diagnostics from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Companion Diagnostic Technologies Market Size and Growth Rate of Oncology from 2016 to 2027

      • 1.4.2 USA Companion Diagnostic Technologies Market Size and Growth Rate of Cardiovascular from 2016 to 2027

      • 1.4.3 USA Companion Diagnostic Technologies Market Size and Growth Rate of Central Nervous System from 2016 to 2027

      • 1.4.4 USA Companion Diagnostic Technologies Market Size and Growth Rate of Auto immune & Inflammation from 2016 to 2027

      • 1.4.5 USA Companion Diagnostic Technologies Market Size and Growth Rate of Virology from 2016 to 2027

      • 1.4.6 USA Companion Diagnostic Technologies Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Companion Diagnostic Technologies Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Companion Diagnostic Technologies by Major Types

      • 3.4.1 Market Size and Growth Rate of Immunohistochemistry

      • 3.4.2 Market Size and Growth Rate of Molecular Diagnostics

    4 Segmentation of Companion Diagnostic Technologies Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Companion Diagnostic Technologies by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Companion Diagnostic Technologies in Oncology

      • 4.4.2 Market Size and Growth Rate of Companion Diagnostic Technologies in Cardiovascular

      • 4.4.3 Market Size and Growth Rate of Companion Diagnostic Technologies in Central Nervous System

      • 4.4.4 Market Size and Growth Rate of Companion Diagnostic Technologies in Auto immune & Inflammation

      • 4.4.5 Market Size and Growth Rate of Companion Diagnostic Technologies in Virology

      • 4.4.6 Market Size and Growth Rate of Companion Diagnostic Technologies in Others

    5 Market Analysis by Regions

    • 5.1 USA Companion Diagnostic Technologies Production Analysis by Regions

    • 5.2 USA Companion Diagnostic Technologies Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Companion Diagnostic Technologies Landscape Analysis

    • 6.1 West USA Companion Diagnostic Technologies Landscape Analysis by Major Types

    • 6.2 West USA Companion Diagnostic Technologies Landscape Analysis by Major End-Users

    7 South USA Companion Diagnostic Technologies Landscape Analysis

    • 7.1 South USA Companion Diagnostic Technologies Landscape Analysis by Major Types

    • 7.2 South USA Companion Diagnostic Technologies Landscape Analysis by Major End-Users

    8 Middle West USA Companion Diagnostic Technologies Landscape Analysis

    • 8.1 Middle West USA Companion Diagnostic Technologies Landscape Analysis by Major Types

    • 8.2 Middle West USA Companion Diagnostic Technologies Landscape Analysis by Major End-Users

    9 Northeast USA Companion Diagnostic Technologies Landscape Analysis

    • 9.1 Northeast USA Companion Diagnostic Technologies Landscape Analysis by Major Types

    • 9.2 Northeast USA Companion Diagnostic Technologies Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Dako (Agilent Technologies)

        • 10.1.1 Dako (Agilent Technologies) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Qiagen

        • 10.2.1 Qiagen Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Abbott Laboratories

        • 10.3.1 Abbott Laboratories Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Thermo Fisher Scientific

        • 10.4.1 Thermo Fisher Scientific Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Resonance Health Ltd

        • 10.5.1 Resonance Health Ltd Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Roche

        • 10.6.1 Roche Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Myriad Genetics

        • 10.7.1 Myriad Genetics Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Danaher

        • 10.8.1 Danaher Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Leica Microsystems

        • 10.9.1 Leica Microsystems Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 bioMerieux

        • 10.10.1 bioMerieux Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Immunohistochemistry from 2016 to 2027

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Molecular Diagnostics from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Cardiovascular from 2016 to 2027

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Central Nervous System from 2016 to 2027

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Auto immune & Inflammation from 2016 to 2027

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Virology from 2016 to 2027

    • Figure USA Companion Diagnostic Technologies Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Companion Diagnostic Technologies Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Companion Diagnostic Technologies Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Companion Diagnostic Technologies

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Companion Diagnostic Technologies by Different Types from 2016 to 2027

    • Table Consumption Share of Companion Diagnostic Technologies by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Immunohistochemistry

    • Figure Market Size and Growth Rate of Molecular Diagnostics

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Companion Diagnostic Technologies by Different End-Users from 2016 to 2027

    • Table Consumption Share of Companion Diagnostic Technologies by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of Central Nervous System

    • Figure Market Size and Growth Rate of Auto immune & Inflammation

    • Figure Market Size and Growth Rate of Virology

    • Figure Market Size and Growth Rate of Others

    • Table USA Companion Diagnostic Technologies Production by Regions

    • Table USA Companion Diagnostic Technologies Production Share by Regions

    • Figure USA Companion Diagnostic Technologies Production Share by Regions in 2016

    • Figure USA Companion Diagnostic Technologies Production Share by Regions in 2021

    • Figure USA Companion Diagnostic Technologies Production Share by Regions in 2027

    • Table USA Companion Diagnostic Technologies Consumption by Regions

    • Table USA Companion Diagnostic Technologies Consumption Share by Regions

    • Figure USA Companion Diagnostic Technologies Consumption Share by Regions in 2016

    • Figure USA Companion Diagnostic Technologies Consumption Share by Regions in 2021

    • Figure USA Companion Diagnostic Technologies Consumption Share by Regions in 2027

    • Table West USA Companion Diagnostic Technologies Consumption by Types from 2016 to 2027

    • Table West USA Companion Diagnostic Technologies Consumption Share by Types from 2016 to 2027

    • Figure West USA Companion Diagnostic Technologies Consumption Share by Types in 2016

    • Figure West USA Companion Diagnostic Technologies Consumption Share by Types in 2021

    • Figure West USA Companion Diagnostic Technologies Consumption Share by Types in 2027

    • Table West USA Companion Diagnostic Technologies Consumption by End-Users from 2016 to 2027

    • Table West USA Companion Diagnostic Technologies Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Companion Diagnostic Technologies Consumption Share by End-Users in 2016

    • Figure West USA Companion Diagnostic Technologies Consumption Share by End-Users in 2021

    • Figure West USA Companion Diagnostic Technologies Consumption Share by End-Users in 2027

    • Table South USA Companion Diagnostic Technologies Consumption by Types from 2016 to 2027

    • Table South USA Companion Diagnostic Technologies Consumption Share by Types from 2016 to 2027

    • Figure South USA Companion Diagnostic Technologies Consumption Share by Types in 2016

    • Figure South USA Companion Diagnostic Technologies Consumption Share by Types in 2021

    • Figure South USA Companion Diagnostic Technologies Consumption Share by Types in 2027

    • Table South USA Companion Diagnostic Technologies Consumption by End-Users from 2016 to 2027

    • Table South USA Companion Diagnostic Technologies Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Companion Diagnostic Technologies Consumption Share by End-Users in 2016

    • Figure South USA Companion Diagnostic Technologies Consumption Share by End-Users in 2021

    • Figure South USA Companion Diagnostic Technologies Consumption Share by End-Users in 2027

    • Table Middle West USA Companion Diagnostic Technologies Consumption by Types from 2016 to 2027

    • Table Middle West USA Companion Diagnostic Technologies Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Companion Diagnostic Technologies Consumption Share by Types in 2016

    • Figure Middle West USA Companion Diagnostic Technologies Consumption Share by Types in 2021

    • Figure Middle West USA Companion Diagnostic Technologies Consumption Share by Types in 2027

    • Table Middle West USA Companion Diagnostic Technologies Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Companion Diagnostic Technologies Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Companion Diagnostic Technologies Consumption Share by End-Users in 2016

    • Figure Middle West USA Companion Diagnostic Technologies Consumption Share by End-Users in 2021

    • Figure Middle West USA Companion Diagnostic Technologies Consumption Share by End-Users in 2027

    • Table Northeast USA Companion Diagnostic Technologies Consumption by Types from 2016 to 2027

    • Table Northeast USA Companion Diagnostic Technologies Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Companion Diagnostic Technologies Consumption Share by Types in 2016

    • Figure Northeast USA Companion Diagnostic Technologies Consumption Share by Types in 2021

    • Figure Northeast USA Companion Diagnostic Technologies Consumption Share by Types in 2027

    • Table Northeast USA Companion Diagnostic Technologies Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Companion Diagnostic Technologies Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Companion Diagnostic Technologies Consumption Share by End-Users in 2016

    • Figure Northeast USA Companion Diagnostic Technologies Consumption Share by End-Users in 2021

    • Figure Northeast USA Companion Diagnostic Technologies Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Dako (Agilent Technologies)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dako (Agilent Technologies)

    • Figure Sales and Growth Rate Analysis of Dako (Agilent Technologies)

    • Figure Revenue and Market Share Analysis of Dako (Agilent Technologies)

    • Table Product and Service Introduction of Dako (Agilent Technologies)

    • Table Company Profile and Development Status of Qiagen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen

    • Figure Sales and Growth Rate Analysis of Qiagen

    • Figure Revenue and Market Share Analysis of Qiagen

    • Table Product and Service Introduction of Qiagen

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Resonance Health Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Resonance Health Ltd

    • Figure Sales and Growth Rate Analysis of Resonance Health Ltd

    • Figure Revenue and Market Share Analysis of Resonance Health Ltd

    • Table Product and Service Introduction of Resonance Health Ltd

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Myriad Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics

    • Figure Sales and Growth Rate Analysis of Myriad Genetics

    • Figure Revenue and Market Share Analysis of Myriad Genetics

    • Table Product and Service Introduction of Myriad Genetics

    • Table Company Profile and Development Status of Danaher

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher

    • Figure Sales and Growth Rate Analysis of Danaher

    • Figure Revenue and Market Share Analysis of Danaher

    • Table Product and Service Introduction of Danaher

    • Table Company Profile and Development Status of Leica Microsystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Leica Microsystems

    • Figure Sales and Growth Rate Analysis of Leica Microsystems

    • Figure Revenue and Market Share Analysis of Leica Microsystems

    • Table Product and Service Introduction of Leica Microsystems

    • Table Company Profile and Development Status of bioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of bioMerieux

    • Figure Sales and Growth Rate Analysis of bioMerieux

    • Figure Revenue and Market Share Analysis of bioMerieux

    • Table Product and Service Introduction of bioMerieux


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US